IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  05/27 04:00:00 pm EDT
398.61 USD   +3.56%
05/19Goldman Sachs Adjusts IDEXX Laboratories' Price Target to $530 From $615, Maintains Neutral Rating
MT
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IDEXX Laboratories to Launch New Diagnostic Tests for Animal Cancer

01/13/2022 | 07:56am EDT


© MT Newswires 2022
All news about IDEXX LABORATORIES, INC.
05/19Goldman Sachs Adjusts IDEXX Laboratories' Price Target to $530 From $615, Maintains Neu..
MT
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K..
AQ
05/05JPMorgan Adjusts Price Target for IDEXX Laboratories to $625 From $725, Maintains Overw..
MT
05/05Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $603 from $732, Keeps Overwe..
MT
05/05BofA Securities Downgrades IDEXX Laboratories to Neutral From Buy, Adjusts Price Target..
MT
05/04IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
05/04Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13..
CI
05/04SECTOR UPDATE : Health Care Stocks Climb Pre-Bell Wednesday
MT
05/04TRANSCRIPT : IDEXX Laboratories, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 447 M - -
Net income 2022 721 M - -
Net Debt 2022 817 M - -
P/E ratio 2022 47,4x
Yield 2022 -
Capitalization 33 486 M 33 486 M -
EV / Sales 2022 9,95x
EV / Sales 2023 8,89x
Nbr of Employees 10 350
Free-Float 77,9%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 398,61 $
Average target price 541,13 $
Spread / Average Target 35,8%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-39.46%33 486
ABBOTT LABORATORIES-17.09%204 317
MEDTRONIC PLC-4.22%131 850
STRYKER CORPORATION-11.56%89 433
BECTON, DICKINSON AND COMPANY2.74%73 108
HOYA CORPORATION-19.93%39 352